Abbott
Health care products (medical devices, diagnostics, nutrition, branded generics) · United States
Abbott makes and sells medical devices such as FreeStyle Libre glucose sensors and heart devices, diagnostic tests and lab systems, Similac and Ensure nutrition, and branded generic medicines in emerging markets, in more than 160 countries.
What makes it different
A wearable glucose sensor is now its biggest product line.
$7.6BContinuous glucose monitor salesFY2025
FreeStyle Libre sensors are replaced every couple of weeks, so each user keeps buying.
How big it is
How big is Abbott?
$44.3BNet salesFY2025
115,000EmployeesFY2025
160+CountriesFY2025
How it makes money FY2025
Medical devices are half the sales.
- Medical Devices48%$21.4B
- Diagnostics20%$8.9B
- Nutrition19%$8.5B
- Established Pharmaceuticals13%$5.5B
How the business works
Sense, test, feed, treat.
- 1FreeStyle Libre glucose sensors
- 2Lab and rapid diagnostics
- 3Similac and Ensure nutrition
- 4Heart devices, branded generics
Most sales are outside the U.S.: $27.2 billion of $44.3 billion in 2025.
Who owns it
- The Vanguard Group10.05%
- BlackRock, Inc.7.7%
CEO: Robert B. Ford
Who it competes with
Key moments
- 1888Dr. Wallace C. Abbott starts making medicine granules in Chicago
- 1964Buys M&R Dietetics, maker of Similac
- 2013Separates AbbVie, its research-based pharmaceuticals business
- 2014Launches FreeStyle Libre
- 2017Acquires St. Jude Medical for about $23.6 billion
Sources
Every number on this page comes from Abbott's own reports.
Full profile
The rest of the story is in the app.
What Abbott tracks24 metrics
Employees
Countries served
People served
Results, quarter by quarterwith a chart
Revenue
Profit
Margin
Where the money comes from8 regions
United States
Germany
China
The full timeline14 moments
2017
2024
2026
Abbott vs Rocheside by side
Revenue
Profit
People
Point your phone at a logo.
See the company behind it.
The full story in 12 chapters · compare any two companies · 335 companies, and any other on request.
Download on the App Store
